Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Accenture
Mallinckrodt
Healthtrust
Johnson and Johnson
UBS
McKinsey
Cipla
Chubb
Boehringer Ingelheim

Generated: January 21, 2018

DrugPatentWatch Database Preview

Sodium phosphate, dibasic, heptahydrate; sodium phosphate, monobasic, anhydrous - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for sodium phosphate, dibasic, heptahydrate; sodium phosphate, monobasic, anhydrous and what is the scope of sodium phosphate, dibasic, heptahydrate; sodium phosphate, monobasic, anhydrous freedom to operate?

Sodium phosphate, dibasic, heptahydrate; sodium phosphate, monobasic, anhydrous
is the generic ingredient in one branded drug marketed by Hospira and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are one thousand four hundred and fifteen drug master file entries for sodium phosphate, dibasic, heptahydrate; sodium phosphate, monobasic, anhydrous. One supplier is listed for this compound.
Summary for sodium phosphate, dibasic, heptahydrate; sodium phosphate, monobasic, anhydrous

US Patents and Regulatory Information for sodium phosphate, dibasic, heptahydrate; sodium phosphate, monobasic, anhydrous

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira SODIUM PHOSPHATES IN PLASTIC CONTAINER sodium phosphate, dibasic, heptahydrate; sodium phosphate, monobasic, anhydrous INJECTABLE;INJECTION 018892-001 May 10, 1983 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Accenture
QuintilesIMS
Express Scripts
Teva
Chubb
Novartis
Harvard Business School
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot